Therapy of pneumocystis carinii pneumonia after trimethoprim-sulfamethoxazole desensitization.
Papakonstantinou
G
G
Medizinische Poliklinik, Ludwig-Maximilians-Universität München.
Füessl
H
H
Matuschke
A
A
Hehlmann
R
R
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D003131:Combined Modality Therapy; D003888:Desensitization, Immunologic; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000628:therapy*; D006801:Humans; D008297:Male; D009894:Opportunistic Infections / Q000188:drug therapy*; D011020:Pneumonia, Pneumocystis / Q000188:drug therapy*; D013420:Sulfamethoxazole / Q000009:adverse effects* / Q000627:therapeutic use; D014295:Trimethoprim / Q000009:adverse effects* / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D004338:Drug Combinations; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole